BridgeMD
New treatment option for Brain Fog
Official title Modulation of the Brain Fog Scale by Eicosapentaenoic Acid Monoglycerides (MAG-EPA).
ClinicalTrials.gov ID: NCT06695910
What this study is testing
- What it's testing
- A growing body of studies shows that omega-3s act directly in molecular signaling pathways that reduce inflammation and are thought to have a positive effect on cognitive health. Brain fog is a term that has been popularized in the medical world in the wake of the COVID-19 pandemic.
- Phase 4: studies an already-approved treatment
- You might receive a placebo (an inactive treatment) instead of the study drug. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 19 to 55. Healthy volunteers may be eligible.
You may be able to join if
- Participant between 19 and 55 years of age.
- Participant who reports having mental fatigue and/or frequent memory loss and/or difficulty concentrating and/or inattention, confusion and/or a...
- Participant who obtains a mean score on the BFS screening questionnaires (BFS1 and BFS2) total of at least 30 and/OR who obtains the following...
- Available for the entire duration of the study and willing to participate based on the information provided in the ICF duly read and signed by the...
- Absence of intellectual problems likely to limit the validity of consent to participate in the study or the compliance with protocol requirements...
You likely can't join if
- Known allergy or intolerance to fish or history of allergic reactions attributable to fish, or to a compound similar to fish oil.
- Participant who has used omega-3 supplements in the 30 days preceding day 1 of the study.
- Pregnant or breastfeeding woman as declared by the latter.
- Presence of dependence on drugs of abuse or alcohol (˃ 3 units of alcohol per day, acute or chronic excessive consumption).
- Participant included in another clinical study and who is receiving an investigational product or other research treatment.
See the full eligibility criteria
- Participant between 19 and 55 years of age.
- Participant who reports having mental fatigue and/or frequent memory loss and/or difficulty concentrating and/or inattention, confusion and/or a feeling of decreased cognitive acuity for at least 28 days at the time of...
- Participant who obtains a mean score on the BFS screening questionnaires (BFS1 and BFS2) total of at least 30 and/OR who obtains the following minimum score on at least one of the three factors: Factor 1 of at least 15...
- Available for the entire duration of the study and willing to participate based on the information provided in the ICF duly read and signed by the latter.
- Absence of intellectual problems likely to limit the validity of consent to participate in the study or the compliance with protocol requirements, ability to cooperate adequately, ability to understand and observe the...
- Participant having no difficulty in swallowing tablets, capsules or gelcaps.
- Known allergy or intolerance to fish or history of allergic reactions attributable to fish, or to a compound similar to fish oil.
- Participant who has used omega-3 supplements in the 30 days preceding day 1 of the study.
- Pregnant or breastfeeding woman as declared by the latter.
- Presence of dependence on drugs of abuse or alcohol (˃ 3 units of alcohol per day, acute or chronic excessive consumption).
- Participant included in another clinical study and who is receiving an investigational product or other research treatment.
The study team makes the final eligibility decision.
Where it's taking place
- Maria, Quebec, Canada
- Rimouski, Quebec, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 19 years to 55 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Maria, Quebec, Canada; Rimouski, Quebec, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.